Hear experts discuss the key considerations for tech transfer and present how a customized modeling tool can help streamline the scale-up of your oral small molecule program.
This week's Fierce Drug Delivery is brought to you by Catalent.
Date: Wednesday, January 27, 2021Time: 10am ET / 7am PTDuration: 1 Hour
The transition from early phase to late phase of a small molecule program plays a pivotal role in determining a program’s ultimate success. Join this webinar to hear experts discuss the key considerations for tech transfer and present how a customized modeling tool can help streamline the scale-up of your oral small molecule program.
Identification of critical material attributes (CMA), critical process parameter (CPP) and critical quality attributes (CQA) of drug product and how to predict their impact on a formulation and manufacturing processes
Overview of primary processing technology in OSD manufacturing and how material characteristics dictate the unit operations method.
Overview of Catalent’s Manufacturing Solutions
You are currently subscribed as newsletter@newslettercollector.com If you no longer wish to receive promotions from Fierce LifeSciences, simply unsubscribe. Refer to our Privacy Policy.
